SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Dahm Christina C.)
 

Sökning: WFRF:(Dahm Christina C.) > (2020-2024) > Lifestyle factors a...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00009450naa a2201105 4500
001oai:lup.lub.lu.se:494de5fe-0a96-4e95-9cb3-0aa5d1ff1f93
003SwePub
008200127s2020 | |||||||||||000 ||eng|
009oai:DiVA.org:umu-168685
0247 a https://lup.lub.lu.se/record/494de5fe-0a96-4e95-9cb3-0aa5d1ff1f932 URI
0247 a https://doi.org/10.1186/s12916-019-1474-72 DOI
0247 a https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-1686852 URI
040 a (SwePub)lud (SwePub)umu
041 a engb eng
042 9 SwePub
072 7a art2 swepub-publicationtype
072 7a ref2 swepub-contenttype
1001 a Freisling, Heinzu International Agency for Research on Cancer, World Health Organization4 aut
2451 0a Lifestyle factors and risk of multimorbidity of cancer and cardiometabolic diseases : a multinational cohort study
264 c 2020-01-10
264 1b Springer Science and Business Media LLC,c 2020
520 a BACKGROUND: Although lifestyle factors have been studied in relation to individual non-communicable diseases (NCDs), their association with development of a subsequent NCD, defined as multimorbidity, has been scarcely investigated. The aim of this study was to investigate associations between five lifestyle factors and incident multimorbidity of cancer and cardiometabolic diseases. METHODS: In this prospective cohort study, 291,778 participants (64% women) from seven European countries, mostly aged 43 to 58 years and free of cancer, cardiovascular disease (CVD), and type 2 diabetes (T2D) at recruitment, were included. Incident multimorbidity of cancer and cardiometabolic diseases was defined as developing subsequently two diseases including first cancer at any site, CVD, and T2D in an individual. Multi-state modelling based on Cox regression was used to compute hazard ratios (HR) and 95% confidence intervals (95% CI) of developing cancer, CVD, or T2D, and subsequent transitions to multimorbidity, in relation to body mass index (BMI), smoking status, alcohol intake, physical activity, adherence to the Mediterranean diet, and their combination as a healthy lifestyle index (HLI) score. Cumulative incidence functions (CIFs) were estimated to compute 10-year absolute risks for transitions from healthy to cancer at any site, CVD (both fatal and non-fatal), or T2D, and to subsequent multimorbidity after each of the three NCDs. RESULTS: During a median follow-up of 11 years, 1910 men and 1334 women developed multimorbidity of cancer and cardiometabolic diseases. A higher HLI, reflecting healthy lifestyles, was strongly inversely associated with multimorbidity, with hazard ratios per 3-unit increment of 0.75 (95% CI, 0.71 to 0.81), 0.84 (0.79 to 0.90), and 0.82 (0.77 to 0.88) after cancer, CVD, and T2D, respectively. After T2D, the 10-year absolute risks of multimorbidity were 40% and 25% for men and women, respectively, with unhealthy lifestyle, and 30% and 18% for men and women with healthy lifestyles. CONCLUSION: Pre-diagnostic healthy lifestyle behaviours were strongly inversely associated with the risk of cancer and cardiometabolic diseases, and with the prognosis of these diseases by reducing risk of multimorbidity.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Cancer och onkologi0 (SwePub)302032 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cancer and Oncology0 (SwePub)302032 hsv//eng
650 7a MEDICIN OCH HÄLSOVETENSKAPx Hälsovetenskapx Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi0 (SwePub)303022 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Health Sciencesx Public Health, Global Health, Social Medicine and Epidemiology0 (SwePub)303022 hsv//eng
653 a Cancer
653 a Cancer and cardiometabolic multimorbidity
653 a Cardiovascular disease
653 a Diabetes
653 a Healthy lifestyle
653 a Obesity
653 a Prevention
653 a Cancer
7001 a Viallon, Vivianu International Agency for Research on Cancer, World Health Organization4 aut
7001 a Lennon, Hannahu International Agency for Research on Cancer, World Health Organization4 aut
7001 a Bagnardi, Vincenzou University of Milano-Bicocca4 aut
7001 a Ricci, Cristianu North-West University4 aut
7001 a Butterworth, Adam S.u University of Cambridge4 aut
7001 a Sweeting, Michaelu University of Cambridge4 aut
7001 a Muller, Davidu Imperial College London4 aut
7001 a Romieu, Isabelleu International Agency for Research on Cancer, World Health Organization4 aut
7001 a Bazelle, Paulineu International Agency for Research on Cancer, World Health Organization4 aut
7001 a Kvaskoff, Marinau University of Paris-Saclay,Centre for Research in Epidemiology and Population Health (CESP)4 aut
7001 a Arveux, Patricku Centre for Research in Epidemiology and Population Health (CESP),Breast and Gynaecologic Cancer Registry of Côte d'Or,Centre Georges-François Leclerc4 aut
7001 a Severi, Gianlucau Centre for Research in Epidemiology and Population Health (CESP),Human Genetics Foundation (HuGeF),University of Paris-Saclay4 aut
7001 a Bamia, Christinau National and Kapodistrian University of Athens,Hellenic Health Foundation, Athens4 aut
7001 a Kühn, Tilmanu German Cancer Research Centre4 aut
7001 a Kaaks, Rudolfu German Cancer Research Centre4 aut
7001 a Bergmann, Manuelau German Institute of Human Nutrition4 aut
7001 a Boeing, Heineru German Institute of Human Nutrition4 aut
7001 a Tjønneland, Anneu Danish Cancer Society4 aut
7001 a Olsen, Anjau Danish Cancer Society4 aut
7001 a Overvad, Kimu Aarhus University4 aut
7001 a Dahm, Christina C.u Aarhus University4 aut
7001 a Menéndez, Virginiau Public Health Directorate4 aut
7001 a Agudo, Antoniou Bellvitge University Hospital-IDIBELL,Bellvitge Biomedical Research Institute,L'Hospitalet de Llobregat, Barcelona,University of Oxford4 aut
7001 a Sánchez, Maria Joseu University of Granada,CIBER Epidemiology and Public Health (CIBERESP)4 aut
7001 a Amiano, Pilaru Biodonostia Health Research Institute,CIBER Epidemiology and Public Health (CIBERESP)4 aut
7001 a Santiuste, Carmenu Murcia Regional Health Council4 aut
7001 a Gurrea, Aurelio Barricarteu CIBER Epidemiology and Public Health (CIBERESP)4 aut
7001 a Tong, Tammy Y.N.u University of Oxford4 aut
7001 a Schmidt, Julie A.u University of Oxford4 aut
7001 a Tzoulaki, Ioannau Imperial College London,University of Ioannina4 aut
7001 a Tsilidis, Konstantinos K.u University of Ioannina,Imperial College London4 aut
7001 a Ward, Heatheru Imperial College London4 aut
7001 a Palli, Domenicou Institute for Cancer Research, Prevention and Clinical Network (ISPRO)4 aut
7001 a Agnoli, Claudiau Istituto Nazionale dei Tumori4 aut
7001 a Tumino, Rosariou Civic and M.P Arezzo Hospital4 aut
7001 a Ricceri, Fulviou Citta' della Salute e della Scienza Hospital-University of Turin4 aut
7001 a Panico, Salvatoreu University of Naples Federico II4 aut
7001 a Picavet, H. Susan J.u National Institute for Public Health and the Environment (RIVM)4 aut
7001 a Bakker, Marijeu University Medical Center Utrecht4 aut
7001 a Monninkhof, Evelynu University Medical Center Utrecht4 aut
7001 a Nilsson, Peteru Umeå universitet,Umeå University,Näringsforskning4 aut
7001 a Manjer, Jonasu Lund University,Lunds universitet,Kirurgi,Forskargrupper vid Lunds universitet,Surgery,Lund University Research Groups,Skåne University Hospital4 aut0 (Swepub:lu)smi-jma
7001 a Rolandsson, Olovu Umeå universitet,Umeå University,Allmänmedicin4 aut0 (Swepub:umu)olro0005
7001 a Thysell, Elinu Umeå University4 aut
7001 a Weiderpass, Elisabeteu International Agency for Research on Cancer, World Health Organization4 aut
7001 a Jenab, Mazdau International Agency for Research on Cancer, World Health Organization4 aut
7001 a Riboli, Eliou Imperial College London4 aut
7001 a Vineis, Paolou Imperial College London4 aut
7001 a Danesh, Johnu University of Cambridge4 aut
7001 a Wareham, Nick Ju University of Cambridge4 aut
7001 a Gunter, Marc J.u International Agency for Research on Cancer, World Health Organization4 aut
7001 a Ferrari, Pietrou International Agency for Research on Cancer, World Health Organization4 aut
7102 a International Agency for Research on Cancer, World Health Organizationb University of Milano-Bicocca4 org
7730 t BMC Medicined : Springer Science and Business Media LLCg 18:1q 18:1x 1741-7015
8564 u http://dx.doi.org/10.1186/s12916-019-1474-7x freey FULLTEXT
8564 u https://bmcmedicine.biomedcentral.com/track/pdf/10.1186/s12916-019-1474-7
8564 u https://doi.org/10.1186/s12916-019-1474-7y Fulltext
8564 u https://umu.diva-portal.org/smash/get/diva2:1412214/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print
8564 8u https://lup.lub.lu.se/record/494de5fe-0a96-4e95-9cb3-0aa5d1ff1f93
8564 8u https://doi.org/10.1186/s12916-019-1474-7
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-168685

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy